Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Treasury Shares (2016 - 2025)

Anaptysbio filings provide 5 years of Treasury Shares readings, the most recent being $478000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 5.25% year-over-year to $478000.0, compared with a TTM value of $478000.0 through Dec 2025, down 5.25%, and an annual FY2025 reading of $478000.0, down 5.25% over the prior year.
  • Treasury Shares hit $478000.0 in Q4 2025 for Anaptysbio, down from $490228.0 in the prior quarter.
  • The five-year high for Treasury Shares was $2.6 million in Q2 2025, with the low at $292898.0 in Q1 2025.
  • Median Treasury Shares over the past 4 years was $1.0 million (2022), compared with a mean of $1.3 million.
  • The sharpest move saw Treasury Shares skyrocketed 297.21% in 2024, then plummeted 86.21% in 2025.
  • Year by year, Treasury Shares stood at $1.0 million in 2022, then surged by 106.47% to $2.1 million in 2023, then plummeted by 76.25% to $504500.0 in 2024, then decreased by 5.25% to $478000.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $478000.0, $490228.0, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.